Rare Case of Extracranial Metastases in a Patient with IDH-Mutant Glioblastoma

Glioblastoma are known for its aggressive intracranial course of disease, where the overall survival is less than 18 months. Of late, the World Health Organization has reclassified and renamed secondary glioblastomas as isocitrate dehydrogenase (IDH)-mutant grade 4 astrocytomas, which is relatively...

Descripción completa

Detalles Bibliográficos
Autores principales: Thimma Sudarsan, Rishan, Ramanujan, Vishnu, Rajendran, Adhithyan, Shafi, Sadiya, Patil, Sushma, Ghosh, Siddhartha, Jalali, Rakesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Thieme Medical and Scientific Publishers Pvt. Ltd. 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10635773/
https://www.ncbi.nlm.nih.gov/pubmed/37969678
http://dx.doi.org/10.1055/s-0042-1757425

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10635773/
https://www.ncbi.nlm.nih.gov/pubmed/37969678
http://dx.doi.org/10.1055/s-0042-1757425

Ejemplares similares